Batur M, Cheng Lu-feng, Yan Dong, Parhat K
Department of Pharmacy, Xinjiang Medical University, Urumqi 830054, China.
Zhongguo Zhong Yao Za Zhi. 2008 Aug;33(15):1873-6.
To investigate the protective effect on the mice acute experimental hepatic injury by Flos Gossypium herbaceum extracts (FGF-I, FGF-II).
Experimental hepatic injury model was established by a single intraperitoneal injection of 350 mg x kg(-1) D-CalN in Wistar rats. Serum samples for alanine aminotransferase (ALT), aspartate transferase (AST) level and liver homogenate samples for super oxide dismutase (SOD), malondialdehyde (MDA), Glutathione peroxidese (GSH-PX) activities were assayed.
For acute experimental hepatic injury, FGF-I and FGF-II significantly decrease the serum transaminase activities (P < 0.01). FGF-I increased the SOD activities (P < 0.01), and decreased MDA content only for 50 mg x kg(-1) FGF-I (P < 0.05), no effect on GSH-PX activity was found for them. FGF-II increased the SOD and GSH-PX activity (P < 0.05) with decreased MDA content (P < 0.05).
FGF-I and FGF-II showed significant protective action in mice experimental hepatic injury.
研究草棉花提取物(FGF-I、FGF-II)对小鼠急性实验性肝损伤的保护作用。
通过向Wistar大鼠腹腔内单次注射350mg·kg⁻¹ D-氨基半乳糖建立实验性肝损伤模型。检测血清中丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)水平,以及肝匀浆中超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-PX)活性。
对于急性实验性肝损伤,FGF-I和FGF-II显著降低血清转氨酶活性(P<0.01)。FGF-I增加SOD活性(P<0.01),仅50mg·kg⁻¹ FGF-I降低MDA含量(P<0.05),对GSH-PX活性无影响。FGF-II增加SOD和GSH-PX活性(P<0.05),同时降低MDA含量(P<0.05)。
FGF-I和FGF-II对小鼠实验性肝损伤显示出显著的保护作用。